macladin
laboratori guidotti s.p.a. - claritromicina - claritromicina
kiton
eg s.p.a. - isosorbide mononitrato - isosorbide mononitrato
terazosina teva
teva italia s.r.l. - terazosina - terazosina
winclar
i.b.n. savio s.r.l - claritromicina - claritromicina
soriclar
abiogen pharma s.p.a. - claritromicina - claritromicina
doxazosin zentiva
zentiva italia s.r.l. - doxazosina - doxazosina
clarmac
epifarma s.r.l - claritromicina - claritromicina
isosorbide mononitrato ahcl
accord healthcare limited - isosorbide mononitrato - isosorbide mononitrato
klacid
viatris italia s.r.l. - claritromicina - claritromicina
adempas
bayer ag - riociguat - ipertensione, polmonare - antipertensivi per l'ipertensione arteriosa polmonare - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. l'efficacia è stata dimostrata in un pah della popolazione eziologie di idiopatica o ereditaria ipa o pah associata a malattia del tessuto connettivo. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.